Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. infectious disease prevention
Show results for
Products
Training

Companies

News
Articles
Events

Refine by
Date

  • Older

Infectious Disease Prevention Articles & Analysis

18 news found

Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics Landscape

Vaccitech to Host Virtual KOL Event on VTP-300, a Potential Functional Cure for Chronic Hepatitis B (CHB) Infection, and the Broader CHB Therapeutics Landscape

Chan, head of the Division of Gastroenterology and Hepatology, Director of the Institute of Digestive Disease, the Center for Liver Health, and the Office of Global Engagement. ...

ByVaccitech plc


Thermo Fisher Scientific and Color Health Launch K-12 ReadyCheckGo COVID-19 Testing Solution for Texas Schools

Thermo Fisher Scientific and Color Health Launch K-12 ReadyCheckGo COVID-19 Testing Solution for Texas Schools

Color provides the tools for preventive health and infectious disease management, including testing, vaccinations, and other services, and is responsible for the largest school testing program in the ...

ByThermo Fisher Scientific


Vaccitech Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

Vaccitech Reports Third Quarter 2021 Financial Results and Recent Corporate Developments

Vaccitech is a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. “We continue to advance our promising pipeline with the recent publication of data on our MERS vaccine program. We also anticipate that ...

ByVaccitech plc


ECOMONDO and KEY ENERGY: IEG ready to re-start in total safety

ECOMONDO and KEY ENERGY: IEG ready to re-start in total safety

Should customers require any further assistance, IEG, together with Studio Arletti, will be able to provide customized services. 15 MONTHS OF SAFETY INITIATIVES The SAFE BUSINESS BY IEG protocol, devised in April 2020, has been extended with adhesions to AEFI (Italian Exhibition and Trade Fair Association) and UFI (The Global Association of the Exhibition Industry) protocols and IEG’s ...

ByItalian Exhibition Group S.p.A (IEG)


Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors

Vaccitech Appoints Joseph Scheeren, PharmD, to its Board of Directors

Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announces the appointment of Joseph Scheeren, PharmD, as an independent director to its Board of Directors ...

ByVaccitech plc


Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection

Vaccitech Doses First Patient in HPV001, a Phase 1/2 Clinical Trial of VTP-200 Immunotherapeutic for High-risk Persistent HPV Infection

Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the dosing of the first patient as part of the HPV001 clinical study. ...

ByVaccitech plc


Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Vaccitech Completes $168 Million Series B Financing to Advance Three Clinical Programs Through Phase 2 Results

Vaccitech Ltd (“Vaccitech”), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announces that it has raised $168 million in a Series B financing. ...

ByVaccitech plc


Vaccitech Appoints Two Independent Board Directors

Vaccitech Appoints Two Independent Board Directors

Vaccitech Ltd., a clinical-stage biopharmaceutical company engaged in the discovery and development of novel immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer, today announced the appointment of two new independent directors to its Board of Directors. ...

ByVaccitech plc


NanoPin Technologies Announces a Research Collaboration Agreement to Advance a Rapid Blood-based Test for Tuberculosis and Infectious Diseases

NanoPin Technologies Announces a Research Collaboration Agreement to Advance a Rapid Blood-based Test for Tuberculosis and Infectious Diseases

Diagnostic advances play critical roles in controlling infectious disease outbreaks, supporting prevention efforts, and improving patient treatment outcomes. ...

ByNanoPin Technologies Inc.


Imaxio sells Trolovol® (D-penicillamine) to focus on vaccines

Imaxio sells Trolovol® (D-penicillamine) to focus on vaccines

Imaxio, a biotech company specializing in immunology announces today the sale of Trolovol® (D-penicillamine), a drug for human usage indicated for an orphan disease affecting around 1,200 patients in France. The transaction was facilitated by CMC Consulting Group. ...

ByIMAXIO S.A.


NIH Statement on World Asthma Day 2015

On World Asthma Day 2015, the National Institutes of Health stands with the international community to renew our commitment to advance our understanding of asthma and develop effective strategies to manage and prevent the disease. Within a broad asthma research portfolio, NIH-supported scientists are making progress in understanding how certain ...

ByNational Institute of Environmental Health Sciences (NIEHS)


Illinois County Records Worst Pertussis Outbreak on Record

Illinois County Records Worst Pertussis Outbreak on Record

One Illinois infection control company that has been on the forefront of helping schools, hospitals and institutions battle infectious diseases is EC2, Inc. “An infected person can be contagious from just before the onset of symptoms until up to three weeks after the symptoms began,” reported Ed Chambers, President of EC2, an indoor environmental and ...

ByCochrane & Associates, LLC


Preventing Outbreaks of Streptococcus pneumoniae Infections

Preventing Outbreaks of Streptococcus pneumoniae Infections

Until 2000, Streptococcus pneumoniae infections caused 100,000-135,000 hospitalizations for pneumonia, 6 million cases of ear infections, and 60,000 cases of invasive disease, including 3300 cases of meningitis. Disease figures have improved since a pneumococcal conjugate vaccine was introduced in 2001. ...

ByCochrane & Associates, LLC


Midwest Hospitals on the Lookout for MDR-AB

Midwest Hospitals on the Lookout for MDR-AB

Acinetobacter can cause a variety of diseases, ranging from pneumonia to serious blood or wound infections, and the symptoms vary depending on the disease. ...

ByCochrane & Associates, LLC


Mid-Atlantic Infection Control Professionals Help Healthcare Facilities Battle VRE

Mid-Atlantic Infection Control Professionals Help Healthcare Facilities Battle VRE

As healthcare-associated infections (HAIs) receive increased attention by the U.S. Centers for Disease Control and Prevention (CDC) and the national media, healthcare facilities are under increased pressure to prevent their spread. ...

ByCochrane & Associates, LLC


Infection Control Professionals Battle Burkholderia cepacia

Infection Control Professionals Battle Burkholderia cepacia

White is the President of Sussex Environmental Health Consultants (SEHC), a leading indoor air quality (IAQ) and infectious disease prevention consulting firm. “The organism can also be spread from person-to-person so hospitals, clinics and other locations that may have infected people need to take extra precautions. Proper sanitation and ...

ByCochrane & Associates, LLC


TB Still a Threat across the Mid-Atlantic

TB Still a Threat across the Mid-Atlantic

Tuberculosis, also known as TB, is caused by a bacterium called Mycobacterium tuberculosis. Many people in the United States think that TB is a disease of the past, but that unfortunately is not the case. The Mid-Atlantic region of the country is no exception. In Delaware the Delaware Division of Public Health has an active TB Elimination Program. The goals of the TB Elimination Program ...

ByCochrane & Associates, LLC


CDC Reports California has New ‘Superbug’ Infections

CDC Reports California has New ‘Superbug’ Infections

A deadly bacterium with a gene that produces an enzyme that allows it to disable carbapenam antibiotics was recently reported on by the Centers for Disease Control and Prevention (CDC). The enzyme, Klebsiella pneumonia carbapenamase or KPC, makes the bacteria very difficult to treat even with carbapenam antibiotics, a ‘last resort’ treatment. ...

ByCochrane & Associates, LLC

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT